Skip to main content

Table 1 Demographics of the donors included in this study

From: Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial

Clinical values N = 21
Age (years) 41.0 ± 11.5
Gender (% female) 14.3
Cause of death, n (%)
 Cerebral trauma 13 (61.8)
 Cerebrovascular accident 5 (23.8)
 Others 3 (14.4)
Using of vasoactive drugs, n (%) 18 (85.7)
Cardio-pulmonary resuscitation, n (%) 3 (14.3)
ICU time of donor (days) 4.6 ± 3.5
Donor BMI (kg/m2) 22.3 ± 2.7
Terminal donor Cr (μmol/L) 188.5 ± 113.9
History of arterial hypertension, n (%) 7 (33.3)
History of heart disease, n (%) 0
History of diabetes, n (%) 1 (4.8)
Warm ischemia time (min) 11.1 ± 4.5
  1. ICU intensive care unit, BMI body mass index, Cr creatinine